<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39384659</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1432-0991</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>Current microbiology</Title><ISOAbbreviation>Curr Microbiol</ISOAbbreviation></Journal><ArticleTitle>Invasive Fungal Infections in Immunocompromised Conditions: Emphasis on COVID-19.</ArticleTitle><Pagination><StartPage>400</StartPage><MedlinePgn>400</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00284-024-03916-1</ELocationID><Abstract><AbstractText>The COVID-19 pandemic caused death of 6 million lives globally, primarily from respiratory failure, but also a significant number from invasive fungal co-infections in these patients, owing to the immune dysfunction in hospitalized patients. Such complications occurred more often in critically ill, hospitalized patients particularly those admitted in intensive care units and were reported as the major reason associated with a high mortality rate worldwide. Fungal pathogens most commonly associated with COVID-19 patients comprise members of the Mucorales (such as Rhizopus, Mucor, and Lichtheimia), as well as genera Aspergillus and Candida. In India, the prevalence rate of mucormycosis is relatively high than aspergillosis and candidiasis, and the predisposing risk factors associated with such infections included uncontrolled diabetes, underlying lung disease, leukopenia, neutropenia, malignancies and prolonged steroid therapy. However, co-infection with other fungi, including Alternaria and Scedosporium was also sporadically reported. These devastating invasive fungal infections are associated with differential mortality (high-low) and morbidity rates even after active management. The diagnosis of such infections is often challenging due to lack of sensitivity in contemporary diagnostic methods and poses an enormous challenge to healthcare experts. Thus, the role of early and accurate diagnosis, and management of such fungal infections, is vital in preventing life-threatening situations. Hence, this review focusses primarily on the epidemiology, predisposing risk factors, host environment, diagnosis and treatment of the most common medically important invasive fungal infections in immunocompromised conditions associated with COVID-19.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kaur</LastName><ForeName>Mahaldeep</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MTCC and Gene Bank, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thakur</LastName><ForeName>Payal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MTCC and Gene Bank, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Nandini</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>MTCC and Gene Bank, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choksket</LastName><ForeName>Stanzin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MTCC and Gene Bank, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harshvardhan</LastName><AffiliationInfo><Affiliation>MTCC and Gene Bank, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korpole</LastName><ForeName>Suresh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MTCC and Gene Bank, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bandarupalli</LastName><ForeName>Devadatha</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>MTCC and Gene Bank, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, India. devadatha@imtech.res.in.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. devadatha@imtech.res.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grover</LastName><ForeName>Vishakha</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-7492-0676</Identifier><AffiliationInfo><Affiliation>Dr. HS Judge Institute of Dental Sciences and Hospital, Panjab University, Sector 25, Chandigarh, India. vishakhagrover1976@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Microbiol</MedlineTA><NlmUniqueID>7808448</NlmUniqueID><ISSNLinking>0343-8651</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="Y">Immunocompromised Host</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072742" MajorTopicYN="Y">Invasive Fungal Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009091" MajorTopicYN="N">Mucormycosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>23</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39384659</ArticleId><ArticleId IdType="doi">10.1007/s00284-024-03916-1</ArticleId><ArticleId IdType="pii">10.1007/s00284-024-03916-1</ArticleId></ArticleIdList><ReferenceList><Title>References:</Title><Reference><Citation>Bhattacharya S, Kubiha S, Tyagi P (2021) Fungi and Endocrine Dysfunction. Endotext https://www.ncbi.nlm.nih.gov/books/NBK572246/</Citation></Reference><Reference><Citation>Biswas PS (2021) Vaccine-induced immunological memory in invasive fungal infections—a dream so close yet so far. Front Immunol 12:671068. https://doi.org/10.3389/fimmu.2021.671068</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.671068</ArticleId><ArticleId IdType="pubmed">33968079</ArticleId><ArticleId IdType="pmc">8096976</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Gao Y, Niu X et al (2020) A 5-year review of invasive fungal infection at an Academic Medical Centre. Front Cell Infect Microbiol 10:553648. https://doi.org/10.3389/fcimb.2020.553648</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.553648</ArticleId><ArticleId IdType="pubmed">33194796</ArticleId><ArticleId IdType="pmc">7642834</ArticleId></ArticleIdList></Reference><Reference><Citation>Bongomin F, Gago S, Oladele RO et al (2017) Global and multi-national prevalence of fungal diseases—estimate precision. J Fungus 3:57. https://doi.org/10.3390/jof3040057</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof3040057</ArticleId></ArticleIdList></Reference><Reference><Citation>Shishido AA, Mathew M, Baddley JW (2022) Overview of COVID-19-associated invasive fungal infection. Curr Fungal Infect Rep 16:87–97. https://doi.org/10.1007/s12281-022-00434-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12281-022-00434-0</ArticleId><ArticleId IdType="pubmed">35846240</ArticleId><ArticleId IdType="pmc">9274633</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyedjavadi SS, Bagheri P, Nasiri MJ et al (2022) Fungal infection in Co-infected patients with COVID-19: an overview of case reports/case series and systematic review. Front microbiol 13:888452. https://doi.org/10.3389/fmicb.2022.888452</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.888452</ArticleId><ArticleId IdType="pubmed">35875562</ArticleId><ArticleId IdType="pmc">9298665</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu R, Singla N (2022) COVID-19 and plethora of fungal infections. Curr Fungal Infect Rep 16(2):47–54. https://doi.org/10.1007/s12281-022-00432-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12281-022-00432-2</ArticleId><ArticleId IdType="pubmed">35432691</ArticleId><ArticleId IdType="pmc">8994097</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoenigl M, Seidel D, Sprute R et al (2022) COVID-19-associated fungal infections. Nat Microbiol 7(8):1127–1140. https://doi.org/10.1038/s41564-022-01172-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01172-2</ArticleId><ArticleId IdType="pubmed">35918423</ArticleId><ArticleId IdType="pmc">9362108</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavda VP, Mishra T, Kamaraj S et al (2023) Post-COVID-19 fungal infection in the aged population. Vaccines 11(3):555. https://doi.org/10.3390/vaccines11030555</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030555</ArticleId><ArticleId IdType="pubmed">36992139</ArticleId><ArticleId IdType="pmc">10056493</ArticleId></ArticleIdList></Reference><Reference><Citation>Latgé JP (1999) Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12(2):310–350. https://doi.org/10.1128/CMR.12.2.310</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.12.2.310</ArticleId><ArticleId IdType="pubmed">10194462</ArticleId><ArticleId IdType="pmc">88920</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousavi B, Hedayati MT, Hedayati N et al (2016) Aspergillus species in indoor environments and their possible occupational and public health hazards. Curr Med Mycol 2(1):36–42</Citation><ArticleIdList><ArticleId IdType="doi">10.18869/acadpub.cmm.2.1.36</ArticleId><ArticleId IdType="pubmed">28681011</ArticleId><ArticleId IdType="pmc">5490296</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen AJ, Hubka V, Frisvad JC et al (2017) Polyphasic taxonomy of Aspergillus section Aspergillus (formerly Eurotium), and its occurrence in indoor environments and food. Stud Myco. https://doi.org/10.1016/j.simyco.2017.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.simyco.2017.07.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Houbraken J, Kocsubé S, Visagie CM et al (2020) Classification of Aspergillus, Penicillium, Talaromyces and related genera (Eurotiales): An overview of families, genera, subgenera, sections, series and species. Stud Mycol 95:5–169. https://doi.org/10.1016/j.simyco.2020.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.simyco.2020.05.002</ArticleId><ArticleId IdType="pubmed">32855739</ArticleId><ArticleId IdType="pmc">7426331</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarti A, Chatterjee SS, Das A et al (2011) editors. Invasive aspergillosis in developing countries. Med Mycol J 49:S35–S47. https://doi.org/10.3109/13693786.2010.505206</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13693786.2010.505206</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudramurthy SM, Paul RA, Chakrabarti A et al (2019) Invasive aspergillosis by Aspergillus flavus: epidemiology, diagnosis, antifungal resistance, and management. J fungi (Basel) 5(3):55. https://doi.org/10.3390/jof5030055</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof5030055</ArticleId><ArticleId IdType="pubmed">31266196</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu HY, Chang PH, Huang YS et al (2023) Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan. J Microbiol Immunol Infect 56:207–235. https://doi.org/10.1016/j.jmii.2022.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.12.003</ArticleId><ArticleId IdType="pubmed">36586743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CC, Yu WL (2021) COVID-19 associated with pulmonary aspergillosis: A literature review. J Microbiol Immunol Infect 54(1):46–53. https://doi.org/10.1016/j.jmii.2020.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.09.004</ArticleId><ArticleId IdType="pubmed">33012653</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiurlo M, Mastrangelo A, Ripa M et al (2021) Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes. New Microbiol 44(2):71–83</Citation><ArticleIdList><ArticleId IdType="pubmed">34240742</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong WH, Neu KP (2021) Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect 113:115–129. https://doi.org/10.1016/j.jhin.2021.04.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2021.04.012</ArticleId><ArticleId IdType="pubmed">33891985</ArticleId><ArticleId IdType="pmc">8057923</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitaka H, Kuno T, Takagi H et al (2021) Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis. Mycoses 64(9):993–1001. https://doi.org/10.1111/myc.13292</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/myc.13292</ArticleId><ArticleId IdType="pubmed">33896063</ArticleId><ArticleId IdType="pmc">8251156</ArticleId></ArticleIdList></Reference><Reference><Citation>Alanio A, Dellière S, Fodil S et al (2020) Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med 8(6):e48–e49. https://doi.org/10.1016/S2213-2600(20)30237-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30237-X</ArticleId><ArticleId IdType="pubmed">32445626</ArticleId></ArticleIdList></Reference><Reference><Citation>van Arkel ALE, Rijpstra TA, Belderbos HNA et al (2020) COVID-19–associated pulmonary aspergillosis. Am J Respir Crit Care Med 202(1):132–135. https://doi.org/10.1164/rccm.202004-1038LE</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202004-1038LE</ArticleId><ArticleId IdType="pubmed">32396381</ArticleId><ArticleId IdType="pmc">7328331</ArticleId></ArticleIdList></Reference><Reference><Citation>Bay P, Audureau E, Préau S et al (2024) COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants. Ann Intensive Care 14(1):65. https://doi.org/10.1186/s13613-024-01318-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-024-01318-x</ArticleId><ArticleId IdType="pubmed">38658426</ArticleId><ArticleId IdType="pmc">11043290</ArticleId></ArticleIdList></Reference><Reference><Citation>Earle K, Valero C, Conn DP et al (2023) Pathogenicity and virulence of Aspergillus fumigatus. Virulence 14:2172264. https://doi.org/10.1080/21505594.2023.2172264</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2023.2172264</ArticleId><ArticleId IdType="pubmed">36752587</ArticleId><ArticleId IdType="pmc">10732619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutsaert L, Steinfort N, Van Hunsel T et al (2020) COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care 10:71. https://doi.org/10.1186/s13613-020-00686-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00686-4</ArticleId><ArticleId IdType="pubmed">32488446</ArticleId><ArticleId IdType="pmc">7265874</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacovelli A, Oliva A, Mirabelli FM et al (2024) Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit. BMC Infect Dis 24(1):392. https://doi.org/10.1186/s12879-024-09283-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09283-3</ArticleId><ArticleId IdType="pubmed">38605300</ArticleId><ArticleId IdType="pmc">11007928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurt W, Youngs J, Ball J et al (2023) COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study. Thorax 79(1):75–82. https://doi.org/10.1136/thorax-2023-220002</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax-2023-220002</ArticleId><ArticleId IdType="pubmed">37657925</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigera LSM, Denning DW (2023) Invasive aspergillosis after renal transplantation. J Fungi (Basel) 9(2):255. https://doi.org/10.3390/jof9020255</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof9020255</ArticleId><ArticleId IdType="pubmed">36836369</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarti A, Singh R (2011) The emerging epidemiology of mould infections in developing countries. Curr Opin Infect Dis 24:521–526. https://doi.org/10.1097/QCO.0b013e32834ab21e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0b013e32834ab21e</ArticleId><ArticleId IdType="pubmed">21799406</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdoli A, Falahi S, Kenarkoohi A (2022) COVID-19-associated opportunistic infections: a snapshot on the current reports. Clin Exp Med 22(3):327–346. https://doi.org/10.1007/s10238-021-00751-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-021-00751-7</ArticleId><ArticleId IdType="pubmed">34424451</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari S, Gupta S, Bhargava S et al (2023) COVID associated invasive aspergillosis. Indian J Otolaryngol Head Neck Surg 75(2):557–562. https://doi.org/10.1007/s12070-022-03367-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-022-03367-9</ArticleId><ArticleId IdType="pubmed">36571095</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Agarwal K, Deepak D et al (2016) Pulmonary aspergillosis: what CT can offer before it is too late! Clin Diagn Res. https://doi.org/10.7860/JCDR/2016/17141.7684</Citation><ArticleIdList><ArticleId IdType="doi">10.7860/JCDR/2016/17141.7684</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Bisht D, Das S et al (2020) Molecular detection of aspergillus in sputum of patients with lower respiratory tract infections. Int J Appl Basic Med Res 10(2):86. https://doi.org/10.4103/ijabmr.IJABMR_364_18</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijabmr.IJABMR_364_18</ArticleId><ArticleId IdType="pubmed">32566523</ArticleId><ArticleId IdType="pmc">7289198</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton RC (2013) Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome. Scientifica. https://doi.org/10.1155/2013/459405</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/459405</ArticleId><ArticleId IdType="pubmed">24278780</ArticleId><ArticleId IdType="pmc">3820361</ArticleId></ArticleIdList></Reference><Reference><Citation>Latgé JP, Chamilos G (2020) Aspergillus fumigatus and aspergillosis in 2019. Clin Microbiol Rev 33(1):10–1128. https://doi.org/10.1128/CMR.00140-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00140-18</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreras-Antolin L, Borman A, Diederichs A et al (2022) Serum Beta-D-glucan in the diagnosis of invasive fungal disease in neonates, children and adolescents: a critical analysis of current data. J Fungi (Basel) 8(12):1262. https://doi.org/10.3390/jof8121262</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof8121262</ArticleId><ArticleId IdType="pubmed">36547595</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquier G, Bounhiol A, Robert Gangneux F et al (2021) A review of significance of Aspergillus detection in airways of ICU COVID-19 patients. Mycoses. https://doi.org/10.1111/myc.13341</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/myc.13341</ArticleId><ArticleId IdType="pubmed">34143533</ArticleId><ArticleId IdType="pmc">8447125</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortorano AM, Esposto MC, Prigitano A et al (2012) Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol. https://doi.org/10.1128/JCM.05946-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.05946-11</ArticleId><ArticleId IdType="pubmed">22573595</ArticleId><ArticleId IdType="pmc">3405602</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuh A, Ramadan N, Shah A et al (2022) Sputum galactomannan has utility in the diagnosis of chronic pulmonary aspergillosis. J Fungi 8(2):188. https://doi.org/10.3390/jof8020188</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof8020188</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosołowski M, Kierzkiewicz M (2013) Etiology, diagnosis and treatment of infectious esophagitis. Prz Gastroenterol 8(6):333–337. https://doi.org/10.5114/pg.2013.39914</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pg.2013.39914</ArticleId><ArticleId IdType="pubmed">24868280</ArticleId><ArticleId IdType="pmc">4027832</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai CS, Lee SSJ, Chen WC et al (2023) COVID-19-associated candidiasis and the emerging concern of Candida auris infections. J Microbiol Immunol Infect 56(4):672–679. https://doi.org/10.1016/j.jmii.2022.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.12.002</ArticleId><ArticleId IdType="pubmed">36543722</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadosh D, Mundodi V (2020) A re-evaluation of the relationship between morphology and pathogenicity in Candida species. J Fungi 6:13. https://doi.org/10.3390/jof6010013</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof6010013</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed N, Mahmood MS, Ullah MA et al (2022) COVID-19-associated Candidiasis: possible patho-mechanism, predisposing factors, and prevention strategies. Curr Microbiol 79:127. https://doi.org/10.1007/s00284-022-02824-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-022-02824-6</ArticleId><ArticleId IdType="pubmed">35287179</ArticleId><ArticleId IdType="pmc">8918595</ArticleId></ArticleIdList></Reference><Reference><Citation>Talapko J, Juzbašić M, Matijević T et al (2021) Candida albicans-the virulence factors and clinical manifestations of infection. J Fungi 7(2):79. https://doi.org/10.3390/jof7020079</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof7020079</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappas PG, Lionakis MS, Arendrup MC et al (2018) Invasive candidiasis. Nat Rev Dis Prim 4:1–20. https://doi.org/10.1038/nrdp.2018.26</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2018.26</ArticleId></ArticleIdList></Reference><Reference><Citation>Logan C, Martin-Loeches I, Bicanic T (2020) Invasive candidiasis in critical care: challenges and future directions. Intensive Care Med 46(11):2001–2014. https://doi.org/10.1007/s00134-020-06240-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06240-x</ArticleId><ArticleId IdType="pubmed">32990778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray A, Adarsh Aayilliath K, Banerjee S et al (2022) Burden of serious fungal infections in India. Open Forum Infect Dis. https://doi.org/10.1093/ofid/ofac603</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac603</ArticleId><ArticleId IdType="pubmed">36589484</ArticleId><ArticleId IdType="pmc">9792086</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudramurthy SM, Chakrabarti A, Paul RA et al (2017) Candida auris candidaemia in Indian ICUs: Analysis of risk factors. J of Antimic Chem 72(6):1794–1801. https://doi.org/10.1093/jac/dkx034</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkx034</ArticleId></ArticleIdList></Reference><Reference><Citation>Larkin E, Hager C, Chandra J, Mukherjee PK et al (2017) The emerging pathogen Candida auris: Growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother 61(5):10–1128. https://doi.org/10.1128/AAC.02396-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.02396-16</ArticleId></ArticleIdList></Reference><Reference><Citation>Spivak ES, Hanson KE (2018) Candida auris: An emerging fungal pathogen. J Clin Microbiol 56:10–128. https://doi.org/10.1128/JCM.01588-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01588-17</ArticleId></ArticleIdList></Reference><Reference><Citation>la Garza PR, Cruz-de la Cruz C, Bejarano JIC (2024) A multicentric outbreak of Candida auris in Mexico: 2020–2023. Am J Infect Control. https://doi.org/10.1016/j.ajic.2024.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2024.07.012</ArticleId><ArticleId IdType="pubmed">39059713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamoth F, Kontoyiannis DP (2018) The Candida auris alert: Facts and perspectives. J Infect Dis 217:516–520. https://doi.org/10.1093/infdis/jix597</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix597</ArticleId><ArticleId IdType="pubmed">29390110</ArticleId></ArticleIdList></Reference><Reference><Citation>Lockhart SR, Etienne KA, Vallabhaneni S et al (2017) Simultaneous emergence of multidrug-resistant candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64(2):134–140. https://doi.org/10.1093/cid/ciw691</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw691</ArticleId><ArticleId IdType="pubmed">27988485</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarti A, Sood P, Rudramurthy SM et al (2015) Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med 41(2):285–295. https://doi.org/10.1007/s00134-014-3603-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3603-2</ArticleId><ArticleId IdType="pubmed">25510301</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Schalkwyk E, Mpembe RS, Thomas J et al (2019) Epidemiologic shift in Candidemia driven by Candida auris, South Africa, 2016–2017. Emerg Infect Dis 25(9):1698. https://doi.org/10.3201/eid2509.190040</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2509.190040</ArticleId><ArticleId IdType="pubmed">31441749</ArticleId><ArticleId IdType="pmc">6711229</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor M, Brizuela M, Raja A (Updated 2023 Jul 4) Oral Candidiasis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan https://www.ncbi.nlm.nih.gov/books/NBK545282/</Citation></Reference><Reference><Citation>R AN, Rafiq NB (Updated 2023 May 29) Candidiasis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan https://www.ncbi.nlm.nih.gov/books/NBK560624/</Citation></Reference><Reference><Citation>Castanheira M, Messer SA, Rhomberg PR et al (2016) Antifungal susceptibility patterns of a global collection of fungal isolates: Results of the SENTRY Antifungal Surveillance Program (2013). Diagn Microbiol Infect Dis 85(2):200–204. https://doi.org/10.1016/j.diagmicrobio.2016.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2016.02.009</ArticleId><ArticleId IdType="pubmed">27061369</ArticleId></ArticleIdList></Reference><Reference><Citation>Clancy CJ, Nguyen MH (2018) Diagnosing invasive candidiasis. J Clin Microbiol. https://doi.org/10.1128/jcm.01909-1710.1128/jcm.01909-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.01909-1710.1128/jcm.01909-17</ArticleId><ArticleId IdType="pubmed">29444828</ArticleId><ArticleId IdType="pmc">5925725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh A, Sarkar A, Paul P et al (2021) The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19. Fungal biol rev 38:67–91. https://doi.org/10.1016/j.fbr.2021.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fbr.2021.09.003</ArticleId><ArticleId IdType="pubmed">34548877</ArticleId><ArticleId IdType="pmc">8445778</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamoth F, Clancy CJ, Tissot F et al (2020) Performance of the T2Candida panel for the diagnosis of intra-abdominal candidiasis. Open Forum Infect Dis. https://doi.org/10.1093/OFID/OFAA075</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/OFID/OFAA075</ArticleId><ArticleId IdType="pubmed">32195291</ArticleId><ArticleId IdType="pmc">7075487</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hatmi AMS, Bonifaz A, Ranque S et al (2018) Current antifungal treatment of fusariosis. Int J Antimicrob Agents 51(3):326–332. https://doi.org/10.1016/j.ijantimicag.2017.06.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2017.06.017</ArticleId><ArticleId IdType="pubmed">28705676</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Diepeningen AD, Brankovics B, Iltes J et al (2015) Diagnosis of fusarium infections: approaches to identification by the clinical mycology laboratory. Curr Fungal Infect Rep 9:135–143. https://doi.org/10.1007/s12281-015-0225-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12281-015-0225-2</ArticleId><ArticleId IdType="pubmed">26301000</ArticleId><ArticleId IdType="pmc">4537702</ArticleId></ArticleIdList></Reference><Reference><Citation>Uscamayta MG, Martin-Onraet A, Espinosa-Bautista K et al (2021) Portal dissemination of fusarium graminearum in a patient with acute lymphoblastic leukemia and febrile neutropenia. Infect Dis Rep 13(1):11–17. https://doi.org/10.3390/idr13010002</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/idr13010002</ArticleId><ArticleId IdType="pubmed">33401374</ArticleId><ArticleId IdType="pmc">7838889</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval-Denis M, Guarnaccia V, Polizzi G et al (2018) Symptomatic citrus trees reveal a new pathogenic lineage in fusarium and two new neocosmospora species. Persoonia 40:1–25. https://doi.org/10.3767/persoonia.2018.40.01</Citation><ArticleIdList><ArticleId IdType="doi">10.3767/persoonia.2018.40.01</ArticleId><ArticleId IdType="pubmed">30504994</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombard L, Sandoval-Denis M, Lamprecht SC et al (2019) Epitypification of Fusarium oxysporum—Clearing the taxonomic chaos. Persoonia 43:1–47. https://doi.org/10.3767/persoonia.2019.43.01</Citation><ArticleIdList><ArticleId IdType="doi">10.3767/persoonia.2019.43.01</ArticleId><ArticleId IdType="pubmed">32214496</ArticleId></ArticleIdList></Reference><Reference><Citation>Crous PW, Lombard L, Sandoval-Denis M et al (2021) Fusarium: more than a node or a foot-shaped basal cell. Stud Mycol 98:100116. https://doi.org/10.1016/j.simyco.2021.100116</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.simyco.2021.100116</ArticleId><ArticleId IdType="pubmed">34466168</ArticleId><ArticleId IdType="pmc">8379525</ArticleId></ArticleIdList></Reference><Reference><Citation>Leslie JF, Summerell BA (2007) The Fusarium Laboratory Manual. John Wiley &amp; Sons</Citation></Reference><Reference><Citation>Erami M, Aboutalebian S, Hezaveh SJH, Ghazvini RD, Momen-Heravi M et al (2023) Microbial and clinical epidemiology of invasive fungal rhinosinusitis in hospitalized COVID-19 patients, the divergent causative agents. Med Mycol. https://doi.org/10.1093/mmy/myad020</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mmy/myad020</ArticleId><ArticleId IdType="pubmed">37715309</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeraphon B, Nakaranurack C, Jutivorakool K et al (2023) Epidemiology and factors associated with treatment success of invasive fungal infections among newly hematologic malignancy patients receiving chemotherapy or hematopoietic stem cell transplant in Thailand. Infect Drug Resist 31:2029–2042. https://doi.org/10.2147/IDR.S405810</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S405810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chae SY, Park HM, Oh TH et al (2020) Fusarium species causing invasive fungal pneumonia in an immunocompetent patient: a case report. Infect Drug Resist 48(12):0300060520976475. https://doi.org/10.1177/030006052097647550</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/030006052097647550</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis F, Benedetti MF, de Abreu MS et al (2022) Invasive fusariosis in a critically ill patient with severe COVID-19 pneumonia: A case report. Med Mycol Case Rep 35:5–8. https://doi.org/10.1016/j.mmcr.2021.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mmcr.2021.12.003</ArticleId><ArticleId IdType="pubmed">34931158</ArticleId></ArticleIdList></Reference><Reference><Citation>Poignon C, Blaize M, Vezinet C et al (2020) Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19. Clin Microbiol Infect 26:1582–1584. https://doi.org/10.1016/j.cmi.2020.06.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.06.026</ArticleId><ArticleId IdType="pubmed">32619736</ArticleId><ArticleId IdType="pmc">7326463</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P, Furfaro D, Cummings MJ et al (2021) Latent class analysis reveals COVID-19–related acute respiratory distress syndrome subgroups with differential responses to corticosteroids. Am J Respir Crit Care Med 204(11):1274–1285. https://doi.org/10.1164/rccm.202105-1302OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202105-1302OC</ArticleId><ArticleId IdType="pubmed">34543591</ArticleId><ArticleId IdType="pmc">8786071</ArticleId></ArticleIdList></Reference><Reference><Citation>Usuda D, Tsuge S, Sugita M et al (2023) Issues in psychiatric hospitals that were revealed through COVID-19 infection countermeasures. Prehosp Disaster Med 38(S1):s173. https://doi.org/10.1017/S1049023X23004491</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1049023X23004491</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino A, Calvo M, Trovato L et al (2023) Mucorales/Fusarium mixed infection in hematologic patient with COVID-19 complications: an unfortunate combination. Pathogens 12(2):304. https://doi.org/10.3390/pathogens12020304</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12020304</ArticleId><ArticleId IdType="pubmed">36839576</ArticleId><ArticleId IdType="pmc">9964160</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen EJ (2006) Fusarium keratitis associated with soft contact lens wear. Arch Opthalmol 124:1183–1184. https://doi.org/10.1001/archopht.124.8.1183</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archopht.124.8.1183</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese JA, Guhan S, Zheng L (2023) Emerging fungal infections and cutaneous manifestations in immunosuppressed patients. Curr Dermatology Rep 12:69–81. https://doi.org/10.1007/s13671-023-00386-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13671-023-00386-9</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy MW, Katragkou A, Iosifidis E et al (2018) Recent advances in the treatment of Scedosporiosis and Fusariosis. J Fungi 4(2):73. https://doi.org/10.3390/jof4020073</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof4020073</ArticleId></ArticleIdList></Reference><Reference><Citation>Boral H, van Diepeningen A, Erdem E et al (2018) Mycotic Keratitis Caused by Fusarium solani sensu stricto (FSSC5): A case series. Mycopathol 183(5):835–840. https://doi.org/10.1007/s11046-018-0280-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11046-018-0280-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucci M, Anaissie E (2007) Fusarium infections in immunocompromised patients. Clin Microbiol Rev 20:695–704. https://doi.org/10.1128/CMR.00014-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00014-07</ArticleId><ArticleId IdType="pubmed">17934079</ArticleId><ArticleId IdType="pmc">2176050</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida M, Kiyota N, Maruyama K et al (2018) Endogenous fusarium endophthalmitis during treatment for acute myeloid leukemia, successfully treated with 25-gauge vitrectomy and antifungal medications. Mycopathologia 183(2):451–457. https://doi.org/10.1007/s11046-017-0221-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11046-017-0221-x</ArticleId><ArticleId IdType="pubmed">29249044</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashida MZ, Seque CA, Enokihara MMSeS et al (2018) Disseminated fusariosis with cutaneous involvement in hematologic malignancies: Report of six cases with high mortality rate. An Bras Dermatol 93(5):726–729. https://doi.org/10.1590/abd1806-4841.20187476</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/abd1806-4841.20187476</ArticleId><ArticleId IdType="pubmed">30156626</ArticleId><ArticleId IdType="pmc">6106674</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Diepeningen AD, Feng P, Ahmed S et al (2015) Spectrum of Fusarium infections in tropical dermatology evidenced by multilocus sequencing typing diagnostics. Mycoses 58(1):48–57. https://doi.org/10.1111/myc.12273</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/myc.12273</ArticleId><ArticleId IdType="pubmed">25530264</ArticleId></ArticleIdList></Reference><Reference><Citation>Paltauf A (1885) Mycosis mucorina. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. Virchows Arch 102(3):543–564. https://doi.org/10.1007/BF01932420</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01932420</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker RD (1957) Mucormycosis—a new disease? J Am Med Assoc 163(10):805–808. https://doi.org/10.1001/jama.1957.02970450007003</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1957.02970450007003</ArticleId><ArticleId IdType="pubmed">13405736</ArticleId></ArticleIdList></Reference><Reference><Citation>Skiada A, Pavleas I, Drogari-Apiranthitou M (2020) Epidemiology and diagnosis of mucormycosis: An update. J Fungi 8:194. https://doi.org/10.3390/jof8020194</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof8020194</ArticleId></ArticleIdList></Reference><Reference><Citation>Walther G, Wagner L, Kurzai O et al (2019) Updates on the taxonomy of mucorales with an emphasis on clinically important taxa. J Fungi 5(4):106. https://doi.org/10.3390/jof5040106</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof5040106</ArticleId></ArticleIdList></Reference><Reference><Citation>Spatafora JW, Chang Y, Benny GL et al (2016) A phylum-level phylogenetic classification of zygomycete fungi based on genome-scale data. Mycologia 108(5):1028–1046. https://doi.org/10.3852/16-042</Citation><ArticleIdList><ArticleId IdType="doi">10.3852/16-042</ArticleId><ArticleId IdType="pubmed">27738200</ArticleId><ArticleId IdType="pmc">6078412</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan MIA, Voigt K et al (2019) Pathogenicity patterns of mucormycosis: Epidemiology, interaction with immune cells and virulence factors. Med Mycol. https://doi.org/10.1093/mmy/myz011</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mmy/myz011</ArticleId><ArticleId IdType="pubmed">30816980</ArticleId><ArticleId IdType="pmc">6394756</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes MZR, Lewis RE, Kontoyiannis DP (2011) Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev 24:411–445. https://doi.org/10.1128/CMR.00056-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00056-10</ArticleId><ArticleId IdType="pubmed">21482731</ArticleId><ArticleId IdType="pmc">3122490</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodríguez JY, Morales-López SE, Rodríguez GJ et al (2018) Necrotizing fasciitis caused by Apophysomyces variabilis in an immunocompetent patient. Med Mycol Case Rep 20:4–6. https://doi.org/10.1016/j.mmcr.2017.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mmcr.2017.12.002</ArticleId><ArticleId IdType="pubmed">30148054</ArticleId></ArticleIdList></Reference><Reference><Citation>Spellberg B, Edwards J, Ibrahim A (2005) Novel perspectives on mucormycosis: Pathophysiology, presentation, and management. Clin Microbiol Rev 18:556–569. https://doi.org/10.1128/CMR.18.3.556-569.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.18.3.556-569.2005</ArticleId><ArticleId IdType="pubmed">16020690</ArticleId><ArticleId IdType="pmc">1195964</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-España JD, Voigt K (2022) An old confusion: Entomophthoromycosis versus mucormycosis and their main differences. Front Microbial. https://doi.org/10.3389/fmicb.2022.1035100</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1035100</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash H, Chakrabarti A (2019) Global epidemiology of mucormycosis. J Fungi 5(1):26. https://doi.org/10.3390/jof5010026</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof5010026</ArticleId></ArticleIdList></Reference><Reference><Citation>Farias LABG, Damasceno LS, Bandeira SP et al (2021) COVID-19 associated Mucormycosis (CAM): Should Brazil be on alert? Rev Soc Bras Med Trop 54:e04102021. https://doi.org/10.1590/0037-8682-0410-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0037-8682-0410-2021</ArticleId><ArticleId IdType="pubmed">34495260</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh AK, Singh R, Joshi SR et al (2021) Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. Diabetes Metab Syndr 15(4):102146. https://doi.org/10.1016/j.dsx.2021.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.05.019</ArticleId><ArticleId IdType="pubmed">34192610</ArticleId><ArticleId IdType="pmc">8137376</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta M, Kumar N, Dhameja N et al (2022) Laboratory diagnosis of mucormycosis: Present perspective. J Family Med Prim Care 11(5):1664. https://doi.org/10.4103/jfmpc.jfmpc_1479_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_1479_21</ArticleId><ArticleId IdType="pubmed">35800582</ArticleId><ArticleId IdType="pmc">9254769</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong N, Jordan AE, Shen X et al (2022) Rhino-orbital cerebral Mucormycosis in a patient with diabetic ketoacidosis: a case report and literature review. Front Neurol 13(4):815902. https://doi.org/10.3389/fneur.2022.815902</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.815902</ArticleId><ArticleId IdType="pubmed">35599740</ArticleId><ArticleId IdType="pmc">9114505</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash H, Chakrabarti A (2021) Epidemiology of mucormycosis in India. Microorganisms 9:523. https://doi.org/10.3390/microorganisms9030523</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9030523</ArticleId><ArticleId IdType="pubmed">33806386</ArticleId><ArticleId IdType="pmc">8000977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim AS, Spellberg B, Walsh TJ et al (2012) Pathogenesis of mucormycosis. Clin Infect Dis 54(SUPPL. 1):S16-22. https://doi.org/10.1093/cid/cir865</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cir865</ArticleId><ArticleId IdType="pubmed">22247441</ArticleId><ArticleId IdType="pmc">3286196</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarti A, Singh R (2014) Mucormycosis in India: Unique features. Mycoses 57:85–90. https://doi.org/10.1111/myc.12243</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/myc.12243</ArticleId><ArticleId IdType="pubmed">25187095</ArticleId></ArticleIdList></Reference><Reference><Citation>Skiada A, Drogari-Apiranthitou M, Pavleas I et al (2022) Global cutaneous Mucormycosis: a systematic review. J Fungi 6:265. https://doi.org/10.3390/jof6040265</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof6040265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan N, Khan NA, Khatri A (2022) Gastrointestinal mucormycosis in the pediatric age group: an evolving disease. Int J Clin Exp Pathol 15(8):323</Citation><ArticleIdList><ArticleId IdType="pubmed">36106073</ArticleId><ArticleId IdType="pmc">9441857</ArticleId></ArticleIdList></Reference><Reference><Citation>Devana SK, Gupta VG, Mavuduru RS et al (2019) Isolated renal mucormycosis in immunocompetent hosts: Clinical spectrum and management approach. Am J Trop Med Hyg 100(4):791. https://doi.org/10.4269/ajtmh.18-0103</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.18-0103</ArticleId><ArticleId IdType="pubmed">30652661</ArticleId><ArticleId IdType="pmc">6447097</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribes JA, Vanover-Sams CL, Baker DJ (2000) Zygomycetes in human disease. Clin Microbiol Rev 13:236–301. https://doi.org/10.1128/cmr.13.2.236-301.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cmr.13.2.236-301.2000</ArticleId><ArticleId IdType="pubmed">10756000</ArticleId><ArticleId IdType="pmc">100153</ArticleId></ArticleIdList></Reference><Reference><Citation>Millon L, Caillot D, Berceanu A et al (2022) Evaluation of serum Mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial. Clin Infect Dis 75(5):777–785. https://doi.org/10.1093/cid/ciab1066</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab1066</ArticleId><ArticleId IdType="pubmed">34986227</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez-Garcia A, Pellon A, Rementeria A et al (2018) Scedosporium and Lomentospora: An updated overview of underrated opportunists. Med Mycol. https://doi.org/10.1093/mmy/myx113</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mmy/myx113</ArticleId><ArticleId IdType="pubmed">29538735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchara JP, Le Govic Y, Kabbara S et al (2020) Advances in understanding and managing Scedosporium respiratory infections in patients with cystic fibrosis. Expert Rev Respir Med 14(3):259–273. https://doi.org/10.1080/17476348.2020.1705787</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2020.1705787</ArticleId><ArticleId IdType="pubmed">31868041</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai P, Singh AK, Anand KB et al (2022) Time versus tissue: timely identification of scedosporium rhinosinusitis in a post-COVID-19 case by MALDI-TOF MS leading to successful management. Med J Armed Forces India 78(3):360–364. https://doi.org/10.1016/j.mjafi.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mjafi.2022.01.014</ArticleId><ArticleId IdType="pubmed">35368449</ArticleId><ArticleId IdType="pmc">8959371</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C et al (2008) Infections caused by Scedosporium spp. Clin Microbiol Rev 21:157–197. https://doi.org/10.1128/CMR.00039</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00039</ArticleId><ArticleId IdType="pubmed">18202441</ArticleId><ArticleId IdType="pmc">2223844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SC, Halliday CL, Hoenigl M et al (2021) Scedosporium and lomentospora infections: contemporary microbiological tools for the diagnosis of invasive disease. J Fungi 7(1):23. https://doi.org/10.3390/jof7010023</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof7010023</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulibaly O, Marinach-Patrice C, Cassagne C et al (2011) Pseudallescheria/Scedosporium complex species identification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Med Mycol 49(6):621–626. https://doi.org/10.3109/13693786.2011.555424</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13693786.2011.555424</ArticleId><ArticleId IdType="pubmed">21281060</ArticleId></ArticleIdList></Reference><Reference><Citation>Revankar SG et al (2004) Dematiaceous fungi. Semin Respir Crit Care Med 25(2):183–189. https://doi.org/10.1055/s-2004-824902</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2004-824902</ArticleId><ArticleId IdType="pubmed">16088461</ArticleId></ArticleIdList></Reference><Reference><Citation>Revankar SG, Sutton DA (2010) Melanized fungi in human disease. Clin Microbiol Rev 23(4):884–928. https://doi.org/10.1128/CMR.00019-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00019-10</ArticleId><ArticleId IdType="pubmed">20930077</ArticleId><ArticleId IdType="pmc">2952981</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Zheng HL, Mei H et al (2022) Phaeohyphomycosis in China. Front Cell Infect Microbiol 12:895329. https://doi.org/10.3389/fcimb.2022.895329</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.895329</ArticleId><ArticleId IdType="pubmed">35770068</ArticleId><ArticleId IdType="pmc">9235401</ArticleId></ArticleIdList></Reference><Reference><Citation>Laosakul K, Youngchim S, Chuamanochan M et al (2020) Phaeohyphomycosis caused by Diaporthe phaseolorum in an immunocompetent patient in Thailand: a case report. Access Microbiol. https://doi.org/10.1099/acmi.0.000128</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/acmi.0.000128</ArticleId><ArticleId IdType="pubmed">32974592</ArticleId><ArticleId IdType="pmc">7497834</ArticleId></ArticleIdList></Reference><Reference><Citation>Revankar SG (2016) Phaeohyphomycosis in transplant patients. J Fungi 2:2. https://doi.org/10.3390/jof2010002</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof2010002</ArticleId></ArticleIdList></Reference><Reference><Citation>Revankar SG, Patterson JE, Sutton DA et al (2002) Disseminated phaeohyphomycosis: Review of an emerging mycosis. Clin Infect Dis 34:467–476. https://doi.org/10.1086/338636</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/338636</ArticleId><ArticleId IdType="pubmed">11797173</ArticleId></ArticleIdList></Reference><Reference><Citation>Araujo R, Oliveira M, Amorim A et al (2015) Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification. Eur J Clin Microbiol 34:1289–1301. https://doi.org/10.1007/s10096-015-2374-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-015-2374-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhary A, Prakash A, Sharma C et al (2018) A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: Role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother 73(4):891–899. https://doi.org/10.1093/jac/dkx480</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkx480</ArticleId><ArticleId IdType="pubmed">29325167</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>